The following services are available at this hospital trust (updated 2021). Men diagnosed at this trust may be able to access additional services from other trusts within the specialist multidisciplinary team:

• Diagnostic Facilities:
• Multiparametric MRI
• Transperineal biopsy under general anaesthetic
• Transrectal ultrasound (TRUS) biopsy
• Choline PET
• PSMA (prostate-specific membrane antigen) PET scan
• Isotope bone scan

• Treatment Facilities:
• Radical prostatectomy
• Robot assisted laparoscopic prostatectomy
• External beam radiotherapy (EBRT)
• Low-dose rate brachytherapy
• High-dose rate brachytherapy
• Stereotactic body radiation therapy (SBRT)
• Chemotherapy
• Clinical trials unit

• Support Service Facilities:
• Advanced PCa CNS
• Urology CNS
• Sexual function services
• Specialist continence services
• Psychological counselling

For these results, data for England were provided for 1st April 2019 to 31st March 2020 from the Rapid Cancer Registration Dataset (RCRD), which is sourced mainly from the Cancer Services and Outcomes Dataset (COSD) containing proxy tumour registrations, as the standard Cancer Registration data were unavailable. More details can be found here.

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	11	1187
Performance Status recorded	82%	92%
TNM completed	64%	72%
Stage variable assigned	82%	95%

	Specialist MDT	National
No. of men with disease status determined	839	34801
Percentage of men diagnosed with metastatic disease	13%	13%

These indicators could not be reported this year for England as we were unable to assign a patient to a particular risk group due to the unavailability of information on PSA and Gleason score in the Rapid Cancer Registration Dataset

	Treatment Centre
No. of men who received radical radiotherapy (2018)	121
Adjusted percentage of men receiving a procedure of the large bowel and a diagnosis indicating radiation toxicity (GI complication) (%)	9%